Adele Noè

1.3k total citations
25 papers, 752 citations indexed

About

Adele Noè is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Adele Noè has authored 25 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Adele Noè's work include Heart Failure Treatment and Management (13 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (3 papers). Adele Noè is often cited by papers focused on Heart Failure Treatment and Management (13 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (3 papers). Adele Noè collaborates with scholars based in Switzerland, United States and Spain. Adele Noè's co-authors include Monica Ligueros‐Saylan, William P. Dole, R. Sarangapani, Gary M. Ksander, Suliman Al‐Fayoumi, Jessie Gu, Arco Y. Jeng, Dean F. Rigel, Suzanne Maahs and Tsu‐Han Lin and has published in prestigious journals such as Circulation, European Heart Journal and Journal of Investigative Dermatology.

In The Last Decade

Adele Noè

25 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adele Noè Switzerland	11	524	135	126	91	57	25	752
Vittoria Mastromarino Italy	14	520 1.0×	78 0.6×	79 0.6×	90 1.0×	80 1.4×	27	708
K Forßmann Germany	10	231 0.4×	139 1.0×	184 1.5×	111 1.2×	183 3.2×	18	627
Yasunori Suematsu Japan	16	495 0.9×	84 0.6×	141 1.1×	134 1.5×	200 3.5×	80	847
Katalin Koltai Hungary	12	226 0.4×	115 0.9×	65 0.5×	92 1.0×	132 2.3×	38	555
Naritsugu Sakaino Japan	12	529 1.0×	123 0.9×	74 0.6×	86 0.9×	207 3.6×	28	860
Ulrike Flierl Germany	19	343 0.7×	57 0.4×	88 0.7×	129 1.4×	228 4.0×	41	846
Masahiro Eriguchi Japan	15	214 0.4×	98 0.7×	101 0.8×	129 1.4×	151 2.6×	60	780
A BLANN United Kingdom	9	413 0.8×	82 0.6×	91 0.7×	101 1.1×	112 2.0×	11	753
Satomi Iwashita Japan	12	592 1.1×	104 0.8×	196 1.6×	72 0.8×	175 3.1×	21	842
Daniel Soliman Canada	10	381 0.7×	266 2.0×	83 0.7×	279 3.1×	170 3.0×	14	741

Countries citing papers authored by Adele Noè

Since Specialization

Citations

This map shows the geographic impact of Adele Noè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Noè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Noè more than expected).

Fields of papers citing papers by Adele Noè

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Noè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Noè. The network helps show where Adele Noè may publish in the future.

Co-authorship network of co-authors of Adele Noè

This figure shows the co-authorship network connecting the top 25 collaborators of Adele Noè. A scholar is included among the top collaborators of Adele Noè based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele Noè. Adele Noè is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Straburzyńska‐Migaj, Ewa, Michele Senni, Rolf Wachter, et al.. (2023). Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study. Journal of Cardiac Failure. 30(3). 425–435. 4 indexed citations

Witte, Klaus K., Rolf Wachter, Michele Senni, et al.. (2022). Influence of Diabetes on Sacubitril/Valsartan Titration and Clinical Outcomes in Patients Hospitalized for Heart Failure. ESC Heart Failure. 10(1). 80–89. 6 indexed citations

Senni, Michele, Rolf Wachter, Klaus K. Witte, et al.. (2019). Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( de novo ) Heart Failure: A Subgroup Analysis of the TRANSITION Study. European Journal of Heart Failure. 22(2). 303–312. 43 indexed citations

Wachter, Rolf, Michele Samaja, Ewa Straburzyńska‐Migaj, et al.. (2019). Initiation of Sacubitril/Valsartan in Patients with De Novo Heart Failure with Reduced Ejection Fraction: An Analysis of the Transition Study. Heart Lung and Circulation. 28. S178–S178. 2 indexed citations

Wachter, Rolf, Michele Samaja, Ewa Straburzyńska‐Migaj, et al.. (2019). In-Hospital Initiation of Sacubitril/Valsartan in Stabilised Patients with Heart Failure and Reduced Ejection Fraction Naïve to Renin-Angiotensin System Blocker: An Analysis of the Transition Study. Heart Lung and Circulation. 28. S177–S178. 2 indexed citations

Pascual‐Figal, Domingo A., Michele Senni, Jan Bělohlávek, et al.. (2018). Abstract 15567: Short-Term Effect on Cardiac Biomarkers of Initiation of Sacubitril/Valsartan in Hospitalized Patients With Heart Failure and Reduced Ejection Fraction: Results of the Transition Study. Circulation. 2 indexed citations

Senni, Michele, Rolf Wachter, Jan Bělohlávek, et al.. (2018). P6531Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF. European Heart Journal. 39(suppl_1). 2 indexed citations

Wachter, Rolf, Michele Senni, Jan Bělohlávek, et al.. (2018). Sacubitril/Valsartan Initiated in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction after Hemodynamic Stabilization: Primary Results of the TRANSITION Study. Journal of Cardiac Failure. 24(8). S15–S15. 5 indexed citations

Pascual‐Figal, Domingo A., Rolf Wachter, Michele Senni, et al.. (2017). Rationale and Design of TRANSITION: A Randomized Trial of Pre-Discharge vs. Post-Discharge Initiation of Sacubitril/Valsartan. ESC Heart Failure. 5(2). 327–336. 33 indexed citations

10.

Bauer, Daniel, Rachel L. Soon, Kenneth Kulmatycki, et al.. (2016). The DGAT1 inhibitor pradigastat does not induce photosensitivity in healthy human subjects: a randomized controlled trial using three defined sunlight exposure conditions. Photochemical & Photobiological Sciences. 15(9). 1155–1162. 8 indexed citations

11.

Filippatos, Gerasimos, Sadiya S. Khan, Andrew P. Ambrosy, et al.. (2015). International REgistry to Assess Medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and Design of a Global Registry. European Journal of Heart Failure. 17(5). 527–533. 46 indexed citations

12.

Howard, Campbell P., Adele Noè, Andrej Skerjanec, et al.. (2014). Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies. Cardiovascular Diabetology. 13(1). 94–94. 44 indexed citations

13.

Noè, Adele, Campbell P. Howard, Tom Thurén, Ann E. Taylor, & Andrej Skerjanec. (2014). Pharmacokinetic and Pharmacodynamic Characteristics of Single-dose Canakinumab in Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics. 36(11). 1625–1637. 27 indexed citations

14.

Pardo, J., J. Font, A. Mena, et al.. (2013). Radiation-induced-cancer risk in breast cancer patients. Photon or electron boost?. Reports of Practical Oncology & Radiotherapy. 18. S181–S181. 1 indexed citations

15.

Noè, Adele, et al.. (2013). Low-dose radiation-induced acute pericarditis (AP) in breast cancer patient. Reports of Practical Oncology & Radiotherapy. 18. S179–S180. 3 indexed citations

16.

Gu, Jessie, Adele Noè, Priya Chandra, et al.. (2009). Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi). The Journal of Clinical Pharmacology. 50(4). 401–414. 406 indexed citations

17.

Kovarik, John M., et al.. (2006). Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus. European Journal of Clinical Pharmacology. 62(5). 361–366. 14 indexed citations

18.

Kovarik, John M., Adele Noè, Louis McMahon, et al.. (2003). Clinical Development of an Everolimus Pediatric Formulation: Relative Bioavailability, Food Effect, and Steady‐State Pharmacokinetics. The Journal of Clinical Pharmacology. 43(2). 141–147. 23 indexed citations

19.

Noè, Adele, et al.. (2002). Stromelysin-1 Activation Correlates with Invasiveness in Squamous Cell Carcinoma11The authors have declared not to have a conflict of interest.. Journal of Investigative Dermatology. 118(5). 759–766. 22 indexed citations

20.

Diener, HC, et al.. (1991). Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. Journal of Neurology. 238(5). 245–250. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact